EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Postexposure Effects of Vaccines on Infectious Diseases

Tara Gallagher, Marc Lipsitch

Epidemiologic Reviews · 31.01.2019 · 41 (1) · 13-27

DOI: 10.1093/epirev/mxz014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epidemiologic Reviews, online erschienen am 04.11.2019. Verfasst von Tara Gallagher und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dartmouth College Department of Physics and Astronomy, Hanover, New Hampshire. Hauptthemen laut MEDLINE: Communicable Diseases, Post-Exposure Prophylaxis, Vaccination. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We searched the PubMed database for clinical trials and observational human studies about postexposure vaccination effects, targeting infections with approved vaccines and vaccines licensed outside the United States against dengue, hepatitis E, malaria, and tick-borne encephalitis. Studies of animal models, serologic testing, and pipeline vaccines were excluded. Eligible studies were evaluated by definition of exposure; attempts to distinguish pre- and postexposure effects were rated on a scale of 1 to 4. We screened 4,518 articles and ultimately identified for this review 14 clinical trials and 31 observational studies spanning 7 of the 28 vaccine-preventable diseases. For secondary attack rate, the following medians were found for postexposure vaccination effectiveness: hepatitis A, 85% (interquartile range (IQR), 28; n = 5 sources); hepatitis B, 85% (IQR, 22; n = 5 sources); measles, 83% (IQR, 21; n = 8 sources); varicella, 67% (IQR: 48; n = 9 sources); smallpox, 45% (IQR, 39; n = 4 sources); and mumps, 38% (IQR, 7; n = 2 sources). For case fatality proportions resulting from rabies and smallpox, the median vaccine postexposure efficacies were 100% (IQR, 0; n = 6 sources) and 63% (IQR, 50; n = 8 sources), respectively. Many available vaccines can modify or preclude disease if administered after exposure. This postexposure effectiveness could be important to consider during vaccine trials and while developing new vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Communicable DiseasesPost-Exposure ProphylaxisVaccinationAdolescentAdultChildChild, PreschoolHumansInfantTreatment OutcomeYoung Adult

Stichwörter der Autor:innen

immunizationimmunotherapyinfectious diseasepostexposure prophylaxisvaccines

Autor:innen und Institutionen

  • Dartmouth College Department of Physics and Astronomy, Hanover, New Hampshire.
  • Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Gallagher, T., & Lipsitch, M. (2019). Postexposure Effects of Vaccines on Infectious Diseases. Epidemiologic Reviews, 41(1), 13-27. https://doi.org/10.1093/epirev/mxz014

Vancouver

Gallagher T, Lipsitch M. Postexposure Effects of Vaccines on Infectious Diseases. Epidemiologic Reviews. 2019;41(1):13-27. doi:10.1093/epirev/mxz014

BibTeX
@article{Gallagher2019,
  author = {Gallagher, Tara and Lipsitch, Marc},
  title = {Postexposure Effects of Vaccines on Infectious Diseases},
  journal = {Epidemiologic Reviews},
  year = {2019},
  volume = {41},
  number = {1},
  pages = {13--27},
  doi = {10.1093/epirev/mxz014}
}
Kostenlos starten →